Thus, some lysozymes could be considered as good chitinases and reciprocally some chitinases can cleave peptidoglycan, the natural substrate of lysozymes. However there is no obvious amino acid sequence similarity found between these two types of enzymes. On the other hand, a different enzyme, chitosanase, also hydrolyses polymer of GlcNAc, but with specificity for a partial or full deacetylation of chitin, named chitosan. The differences in substrate specificity of these enzymes, and occasionally in their catalytic mechanism, make them belong to different protein LY2835219 families with different E.C. number. All these proteins could be considered, to a large extent, as chitinolytic enzymes, i.e. enzymes that are able to hydrolyze derivatives of chitin. Chitinolytic enzymes are widely distributed in the tissues and body fluids of animals, plants and microorganisms and also in the soil- and bio-spheres of the earth. Chitinases are key enzymes in plant defence systems against fungal infection. They are classified on the basis of amino acid sequence in two different GH families, namely GH18 and GH19. Chitinases of GH18 are encountered in all living organisms whereas those of GH19 are mainly found in plants. Proteins of these two GH families significantly differ both in their three-dimensional structures and in their enzymatic mechanisms. Lysozymes are widely spread throughout nature. They are used by plants and higher organisms as a first defence mechanism against bacterial invasion. Since its discovery by Fleming in 1922, lysozyme has been extensively studied. It was one of the first proteins to be completely sequenced and one of the first enzymes for which the X-ray structure was determined. Several classes of lysozymes have been identified on the basis of their sequence similarities. The best known ones are of the Ctype, the G-type and the V-type. Chitosanases are classified in GH46. Most of these enzymes are found in microorganisms and few are found in virus. Although chitinases and chitosanases hydrolyze chemically similar substrates that differ only by an acetyl group, no sequence similarities were found between members of these two families. Polysaccharide-hydrolyzing enzymes commonly use two catalytic residues, a general-acid and a nucleophile/ base residue, and they basically perform their function through two different reaction mechanisms, a single-displacement mechanism with a net inversion of an anomeric carbon configuration and a double-displacement mechanism with a net retention of a substrate configuration. Whereas the catalytic general-acid residue is localized in equivalent positions in the lysozyme superfamily, the general-base residues are not well structurally conserved in the five families, and even in an extreme case, such as in GH23 and GH46 families, no residue with general base function has been identified. Finally, with the exceptions of GH22 lysozymes that are retaining enzymes.
it has been described that the mechanical forces associated with mechanical ventilation provoke an inflammatory response
Loss of integrity of epithelial and endothelial cell monolayers has been suggested to play an important role in the ventilatorinduced disruption of the alveolar-capillary barrier. One of the crucial systems regulating vascular cell integrity is the angiopoietin -Tie2 system. Clarifying the role of the Ang-Tie2 system in the development of lung injury has therefore become a topic of great interest. However, to date little is known about the interaction of mechanical stretch with the Ang-Tie2 system. It has been recognized that Ang-1 serves as a Tie2 receptor agonist by phosphorylating Tie2 on tyrosine residues. Ang-12mediated Tie2 signaling is required to maintain cellular integrity and quiescence of the endothelial barrier. The antagonist Ang-2 is known to downregulate Tie2 signaling, thereby preparing vascular endothelial cells for enhanced responsiveness to factors that cause destabilization of the endothelial barrier. However, there is also conflicting evidence that Ang-2 may cause Tie2 activation in stressed endothelial cells. In a murine model of endotoxin-induced acute lung injury, Karmpaliotis et al. described that vascular permeability and pulmonary edema were accompanied by enhanced vascular endothelial growth factor and reduced Ang-1 levels in lung tissue. The same authors proposed that changes in the balance between VEGF and Ang-1 might contribute to the pathophysiology of ALI. Protective effects of Ang-1 treatment have been shown before in experimental models of endotoxin-induced ALI. Mei et al. demonstrated that treatment with Ang-1 attenuated vascular leakage, granulocyte infiltration and DAPT pro-inflammatory cytokine expression in lungs of endotoxin-exposed mice. Consequently, the AngTie2 system has been proposed as a possible therapeutic target in pulmonary diseases like ALI and its most severe form, the acute respiratory distress syndrome . Vascular leakage and pulmonary inflammation are important features of VILI. Therefore, we hypothesized that Ang-12Tie2 signaling plays a role in the development of VILI. In an attempt to better reflect the human setting, we applied a relatively mild model of VILI using clinically relevant ventilator settings thereby preventing shock, metabolic acidosis and substantial damage to lung architecture. The aim of present study was to investigate the influence of mechanical ventilation on the AngTie2 system in lungs of healthy adult mice. Furthermore, we examined whether treatment with Ang-1, a Tie2 receptor agonist, would protect ventilated mice against important hallmarks of VILI such as inflammation, vascular leakage and impaired gas exchange. In experimental studies, mechanical ventilation has been described to induce destabilization of the alveolar-capillary barrier thereby leading to enhanced pulmonary permeability and edema formation. Most models of VILI, however, applied very high inspiratory pressures or tidal volumes when compared to those used in the human setting.
Important role for phosphatidylinositol and cholesterol during entry of the virus into the target cells
The lipid composition and the curvature of biological membranes are limiting steps for peptide interactions with living cells and liposomes. Cholesterol has been proven to be essential for filovirus replication, and the entry of the Ebola and Marburg viruses is inhibited after cholesterol depletion of the target cells. In cells not depleted of cholesterol, viral proteins co-localize with caveolin after internalization. Caveolae are vesicles enriched with cholesterol and sphingolipids and have been shown to be involved in a wide range of biological events such as cellular entry by certain viruses. In this work, we depleted cholesterol from cells to understand its importance in the mechanism of membrane fusion, an early step in the Ebola infection cycle. Since Vero and BHK-21 mammalian cells are permissive to infection mediated by the Ebola virus, initial attempts were performed by using those cells. b-cyclodextrins were used to since they are very effective to selectively extract cholesterol from membranes of intact cells without binding or insertion into the plasma membrane. Vero and BHK-21 cells were treated with increasing concentrations of MbCD for 30 min at 37uC and then assayed for cholesterol quantification. As shown in Fig. 1A, cholesterol depletion was dose-dependent for Vero and BHK-21 cells. In addition, insect cells, previously grown in medium with cholesterol, were assayed as a cellular control of low cholesterol content cells. Insect cells are cholesterol auxotrophs and can be depleted of cholesterol by growth in delipidated serum. As observed in Fig. 1A, the cholesterol content of C6/36 cells was maintained after incubation with up to 12 mM MbCD. However, upon incubation with 20 and 24 mM MbCD, it was not possible to detect cholesterol due to the low cell adhesion induced by depletion. To determine the effect of MbCD on cell viability, Vero, BHK-21 and C6/36 cells were incubated in the absence or in the presence of MbCD. At the same time we added MTT reagents to prevent cellular loss during the washing step. In general, insect and mammalian cell monolayers were intact after 30 min incubation with up to 16 or 24 mM of MbCD, respectively. Fig. 1B shows that insect cells were more affected by cholesterol depletion than mammalian cells. Indeed, 16 mM MbCD was able to decrease 50–60% of cholesterol in mammalian and insect cells but only affected the viability of insect cells. Thus, our results showed that some different MbCD concentrations can induce similar levels of cholesterol depletion but different responses in cellular viability. In our studies, low MbCD concentrations, which cause depletion of cholesterol but do not affect the cellular viability, were chosen to examine the role played by cholesterol during protein-membrane interaction. Previous studies had shown that low BYL719 endosomal pH is required for infection and cell-cell fusion mediated by Ebola virus GP and that low pH is required for optimal functioning of cathepsin B and L.
There is a soaring need for new therapeutic strategies as well as biomarkers that can achieve effective
Saliva-based translational research and LEE011 technology is now at a mature juncture and can be evaluated to determine its utility for breast cancer detection. Explorative studies have evaluated the potential use of salivary proteins such as c-erbB-2, VEGF, EGF, and CEA in the initial detection and/ or follow-up screening for the recurrence of breast cancer. However, these investigations were not based on biomarker discoveries from saliva specimens, rather they were testing blood biomarkers in saliva. Here, we report the use of transcriptomic and proteomic approaches to discover and pre-validate biomarkers in saliva for the noninvasive detection of breast cancer. Our results demonstrate significant differences in salivary transcriptomic and proteomic profiles between breast cancer patients and controls. The discovered salivary biomarkers possess discriminatory power for the detection of breast cancer, with high specificity and sensitivity. Early detection of breast cancer offers the promise of easier treatment and improved survival. Conventional screening has a less-than-desirable sensitivity and specificity. Our long-term goal is to develop a saliva-based noninvasive tool for the early detection of breast cancer. We envision a clinical context in which a salivary test may enable clinicians to detect breast cancer earlier, and reduce the number of unnecessary biopsies, in a cost-effective manner. The purpose of this study, which is an essential step toward attaining our long-range goal, is to evaluate the potential utilityof salivary transcriptomes and proteomes for breast cancer detection. We applied two high-throughput technologies in order to assess 1) whether the salivary transcriptome and proteome profiles change with the onset of breast cancer, and 2) whether discriminatory biomarkers can be identified and validated. By addressing both questions, our profiling results, and further independent validation of the discovered biomarkers, will open new research directions and support the idea that saliva is a useful biomarker source for breast cancer detection. The salivary transcriptome is a novel diagnostic alphabet we have explored for discovering breast cancer biomarkers. Salivary transcriptional profiling technology has been successfully applied for discovering detection biomarkers of resectable pancreatic cancer. Consistent with that study, high-throughput profiling revealed significant variations in gene signature profiles between the breast cancer patients and the controls, demonstrating that the salivary transcriptome is an informative biomarker source for systemic cancer detection. The gene ontology analysis could categorize the 1301 up/down-regulated genes into various biological processes based on their known roles or functions. Proteomic profiling, without independent validation, has been recently performed for discovering salivary biomarkers using stimulated whole saliva.
locus and the gene has been differentially expressed and confirmed by qRTPCR in good USC outcome
RhoBTB3 is a member of the RHOBTB subfamily of Rho GTPases that play a role in mediating cell size, proliferation, apoptosis, PI-103 survival, polarity, call adhesion and membrane trafficking. Recent studies have suggested that RhoB is involved in tumor suppression. These studies suggested that RhoB was detected in normal tissue yet its expression was dramatically lost during cancer progression in lung and head and neck squamous cell carcinoma. In line with these findings, high expression of RhoB was associated with favorable outcome in bladder cancer. In our study, we suggested that RhoBTB3 might serve as a potential tumor marker for good prognosis in USC. RAS association domain family 7 is located at 11p15.5 and it belongs to the Ras-domain family of ten members that are implicated in various cellular mechanisms including apoptosis, cell cycle control, and microtubule stabilization. They are downregulated by epigenetic mechanisms, indicating the potential role of a tumor suppressor gene. However, this does not currently exist in RASSF7. Recently RASSF7 was found in numerous tissues and knocking down RASSF7 function resulted in blocking spindle formation, triggering a mitotic arrest, nuclear breakdown and apoptosis. This suggests the possibility that RASSF7 could have a role in promoting cancer cell development. In our study the under-expression of RASSF7 in USC correlated with good prognosis and the detection of RASSF7 silencing by methylation study could have potential clinical use for USC prognosis and treatment. Finally, Fibulin1, mapped on 22q13.3 gene, belongs to a family of secreted glycoproteins. Fibulin family has been shown to modulate cell morphology, growth, adhesion and motility. In particular, FBLN1 appeared to have a role in inhibiting cell adhesion, spreading, motility and invasion in human cancer cells. In vivo studies showed increased FBLN1 expression in ovarian and breast carcinomas. Others had showed its downregulation in prostate and gastric cancer. Therefore, speculation still exists regarding FBLN1 as a tumor-suppressor gene or an oncogene or it might even have dual functions. In our study, the over-expression of the FBLN1 protein was observed for good prognosis in EAC. One limitation of this study is the relatively small sample size which does not provide us enough power for statistical analysis of expression levels of DEGs and clinical characteristics. The result should be interpreted with caution because of the small sample size and undetermined molecular mechanisms of novel DEGs. Nevertheless, novel DEGs found in our studies, once narrowed down and verified in future studies with larger cohort, might have potential prognostic and therapeutic effects in each of EAC and USC. In conclusion, although the sample size was small for a definite conclusion, we believe that our findings shed meaningful insights into the clinical study of endometrial cancer patients that warrant further investigation.